CS logo
small CS logo
Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego

Krakow, Poland

About Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego


During the past decade, Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego" #1 collaborator was "KCRI" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego


According to Clinical.Site data, the most researched conditions in "Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego" are "CD20-positive Acute Lymphoblastic Leukemia" (1 trials) and "Myelofibrosis" (1 trials). Many other conditions were trialed in "Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego" in a lesser frequency.

Clinical Trials Intervention Types at Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego


Most popular intervention types in "Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Obinutuzumab" (1 trials), "Rituximab" (1 trials) and "TL-895" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego


The vast majority of trials in "Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego" are 2 trials for "All" genders.

Clinical Trials Status at Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego


Currently, there are NaN active trials in "Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".